Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
MarketWatchPaywall
Read Full Article at MarketWatch →Ad Slot — In-Article (728x90)
Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
This is a summary. For the full story, read the original article at MarketWatch.
Original source: MarketWatch